Relmada Therapeutics Inc
F:4E2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Relmada Therapeutics Inc
F:4E2
|
US |
|
A
|
Advanced Micro Devices Inc
DUS:AMD
|
US |
|
W
|
Western Digital Corp
XMUN:WDC
|
US |
|
B
|
Bristol-Myers Squibb Co
F:BRM
|
US |
|
Z
|
ZEAL Network SE
F:TIMA
|
DE |
|
L
|
Linde PLC
XMUN:LIN
|
UK |
|
V
|
Viscofan SA
XMUN:VIS
|
ES |
|
B
|
Banpu Power PCL
SET:BPP
|
TH |
|
Y
|
Yoc AG
XMUN:YOC
|
DE |
|
A
|
argenx SE
F:1AE
|
NL |
Shareholder Yield
Current shareholder yield for 
Relmada Therapeutics Inc is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Relmada Therapeutics Inc
| Average Annual Return | -44.29% |
| Standard Deviation of Annual Returns | 61.12% |
| Max Drawdown | -97% |
| Market Capitalization | 770.9m EUR |
| Shares Outstanding | 30 099 200 |
| Percentage of Shares Shorted |
N/A
|
